Cassava Sciences, Inc. (NASDAQ: SAVA), is a biotechnology company focused on developing novel, investigational treatments, including simufilam, for central nervous system disorders, such as tuberous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results